CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Extravascular blood pressure transducerdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03056859
NCT03056859N/ACompleted

Central Venous Catheterization in Obese Patients With Compass Device

University of New Mexico·observational·Posted Feb 17, 2017·Updated Jun 27, 2024

In Brief

An observational study evaluating Extravascular blood pressure transducer for Blood Pressure. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This is a single-arm observational trial of a device (Compass Vascular Access, Centurion Medical Products, Williamston MI). The device is a compact, sterile, single-use extravascular blood pressure transducer. This pressure measurement aids in confirmation of appropriate venous access. The investigators plan to enroll 40 consenting patients with BMI ≥35 who require central venous catheterization for clinical reasons independent of the existence of this study. The primary outcome is operator satisfaction.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBlood Pressure
CountriesUnited States

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 17, 2017
Enrollment StartFeb 17, 2017
Primary CompletionFeb 10, 2020
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 9.4 years ago

Interventions

Extravascular blood pressure transducerdevice

Listed device is included in central venous catheter placement apparatus for consenting patients, according to manufacturer directions